SSY Group Limited (HKG:2005)
Hong Kong
· Delayed Price · Currency is HKD 3.020
-0.020 (-0.66%)
Apr 24, 2025, 4:08 PM HKT
SSY Group Revenue
In the year 2024, SSY Group had annual revenue of 5.77B HKD, down -10.67%. SSY Group had revenue of 2.43B in the half year ending December 31, 2024, a decrease of -19.65%.
Revenue
5.77B
Revenue Growth
-10.67%
P/S Ratio
1.54
Revenue / Employee
939.35K
Employees
5,640
Market Cap
8.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.77B | -689.76M | -10.67% |
| Dec 31, 2023 | 6.46B | 28.98M | 0.45% |
| Dec 31, 2022 | 6.43B | 1.08B | 20.11% |
| Dec 31, 2021 | 5.36B | 1.10B | 25.72% |
| Dec 31, 2020 | 4.26B | -374.78M | -8.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |